Scarica l'app Stockscreener
3.60
1.98%
0.07
Precedente Chiudi:
$3.53
Aprire:
$3.6
Volume 24 ore:
8,612
Relative Volume:
1.25
Capitalizzazione di mercato:
$77.90M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+0.00%
1M Prestazione:
+0.00%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$3.53
$3.80
Intervallo di 1 settimana:
$3.06
$3.9059
Portata 52W:
$3.06
$3.9059
Advanced Biomed Inc Stock (ADVB) Company Profile
Nome
Advanced Biomed Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta ADVB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADVB
Advanced Biomed Inc
|
3.60 | 77.90M | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
516.75 | 195.34B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
208.66 | 149.60B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
119.20 | 33.84B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IDXX
Idexx Laboratories Inc
|
413.04 | 33.52B | 3.90B | 887.87M | 798.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
183.79 | 32.24B | 15.41B | 1.37B | 2.11B | 7.50 |
Advanced Biomed Inc Borsa (ADVB) Ultime notizie
Harbour BioMed Launches Élancé Therapeutics to Advance Next-Generation Obesity Therapies - Morningstar
Advanced Biomed Inc. Completes Successful IPO Launch - TipRanks
Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket - Benzinga India
Red-hot market supports two med-tech IPOs in a day - BioWorld Online
A Dynamic Duo: Travis Stancil and Natella Devitskya Celebrate Five Years of Captivating Performances - The Manila Times
Advanced Biomed Inc. Announces Closing of Initial Public Offering Raising $6.56 Million - Nasdaq
Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering - Benzinga
Advanced Biomed prices IPO at $4 per share - MSN
Advanced Biomed Prices 1.6 Million Shares to Raise $6.6 Million in IPO -March 06, 2025 at 09:29 am EST - Marketscreener.com
OverDrive Appoints Eric Miller to Lead the Company's Data and Information Science Services - The Manila Times
ADVB IPO NewsTaiwanese diagnostics developer Advanced Biomed prices downsized US IPO at the $4 low end - Renaissance Capital
Advanced Biomed Inc. Announces Pricing of Initial Public Offering - GlobeNewswire
This Cancer Detection Biotech Just Priced Its Nasdaq IPOKey Details Inside - StockTitan
Can Mainz Biomed's 82% Detection Rate Technology Revolutionize Colorectal Cancer Prevention? - StockTitan
IPO Roundup: Advanced Biomed, Brag House Holdings and more - MSN
HBM Alpha Therapeutics Enters Strategic Collaboration and License Agreement to Advance Novel Endocrine Therapies - PR Newswire
Harbour BioMed and Insilico Medicine Achieve Strategic Collaboration to Advance AI-Driven Antibody Discovery and Development - PR Newswire
Biomedical Engineering Courses: Admission 2025, Fees, Eligibility, Entrance Exams, Syllabus/Subjects, Top Colleges, Career Scope & Salary - Shiksha
Mainz Biomed Launches Major U.S. Study for AI-Powered Colorectal Cancer Detection Test - StockTitan
Moderna Secures $590M Funding From U.S. Government for Bird Flu Jab - Yahoo Finance
Orchestra BioMed shares get shot in the arm on solid clinical trial data - Mugglehead
Mainz Biomed Enters Agreement with Quest Diagnostics to Advance ColoAlert Colorectal Cancer Screening Test - Nasdaq
Fluid Biomed Inc. Raises $27 Million USD in Oversubscribed Series A Financing to Advance World’s First Bioabsorbable Polymer-Based Stent To Treat Brain Aneurysms - Business Wire
FBB Biomed partners with Verici Dx to advance research on neurologic diseases - Corridor Business
Thermo Fisher Scientific and Mainz Biomed Partner to Advance Colorectal Cancer Screening Technology - citybuzz -
Mainz Biomed and Thermo Fisher Scientific Sign a - GlobeNewswire
L&K BIOMED Announces FDA Approval of the BluEX Lumbar Expandable Cage System, Featuring Advanced Surface Technology for Comprehensive Spine Interbody Fusion Options. - Becker's Orthopedic & Spine
Taiwanese diagnostics developer Advanced Biomed slashes deal size by 92% ahead of $9 million US IPO - Renaissance Capital
Thermoelectric Materials and Devices for Advanced Biomedical ApplicationsJia2024Small - Wiley Online Library
Harbour BioMed Announces Publication of the Phase I Study Results for Porustobart in Combination with Toripalimab in Advanced Melanoma and Other Solid Tumors - PR Newswire
AskBio and Belief BioMed partner to advance gene therapies - Pharmaceutical Technology
AskBio to collaborate with Belief BioMed to explore the potential of new gene therapies - Bayer
Polysaccharide-Based Hydrogels for Advanced Biomedical Engineering Applications - ACS Publications
Genexys BioMed Awarded $320K SBIR Grant to Advance Novel Cystic Fibrosis Gene Therapy - PR Newswire
Mainz Biomed seeks FDA’s Breakthrough Devices Designation for advanced colorectal cancer test - News-Medical.Net
Advanced Melanoma Clinical Trial Pipeline Analysis - GlobeNewswire
Harnessing stimuli‐responsive biomaterials for advanced biomedical applicationsLiaoExploration - Wiley Online Library
Adroit Biomed Ltd. Announces Innovative, Technologically Advanced, High-Performance Collagen 'Fortisil C' - ETHealthWorld
Initial Public Offering (IPO) News Live Feed - StockTitan
4D Printing for Biomedical ApplicationsYarali2024Advanced Materials - Wiley Online Library
Crucial Breakthrough of BODIPY-Based NIR-II Fluorescent Emitters for Advanced Biomedical Theranostics - Wiley Online Library
Development and Application of an Advanced Biomedical Material‐Silk Sericin - Wiley Online Library
Research and development - Novartis
BrioHealth Solutions Launches New Corporate Identity and Prepares for Groundbreaking INNOVATE Trial for Advanced Heart Failure Treatment - PR Newswire
Leidos Biomedical Research - Leidos
AmplifyBio and Vector BioMed Partner to Manufacture Plasmids and Share Capabilities that Enhance the Safety and Scalability of Lentiviral-based Gene Therapeutics - Newswire
Ocean Biomedical (NASDAQ: OCEA) Announces $1 Million Falk Award for Malaria Drug Candidate Addressing Evolving Resistance to Artemisinin-Based Therapeutics to Chief Scientist Dr. Jonathan Kurtis - BioSpace
Offerings News Live Feed - StockTitan
Jacqueline Ciron Angeles, MD - The Manila Times
Taiwanese developer of microfluidic testing equipment for early cancer screening. - Renaissance Capital
Advanced Clinical Technology, Inc. (ACT) - MedTech Outlook
Advanced Biomed Inc Azioni (ADVB) Dati Finanziari
Non sono disponibili dati finanziari per Advanced Biomed Inc (ADVB). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.53%
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):